Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Clinical Pharmacology and Therapeutics|June 28, 2002
Bivalirudin pharmacokinetics and pharmacodynamics: effect of renal function, dose, and genderRichard Robson, Harvey White, Philip Aylward, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1988
Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTPI J Kopin, K S Bankiewicz, J Harvey-White
Current Cardiology Reports|May 8, 2014
Universal MI definition update for cardiovascular diseaseHarvey White, Kristian Thygesen, Joseph S Alpert, et al.
European Journal of Pharmacology|April 13, 1988
The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey modelT Brücke, K Bankiewicz, J Harvey-White, et al.
Journal of Cardiovascular Pharmacology|June 16, 2006
2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated heartsJens A Wagner, Marco Abesser, Judith Harvey-White, et al.
American Heart Journal|March 29, 2008
Antiplatelet drug nonresponsivenessPatrick Gladding, Mark Webster, John Ormiston, et al.
International Journal of Obesity (2005)|March 30, 2006
The role of the endocannabinoid system in the control of energy homeostasisD Osei-Hyiaman, J Harvey-White, S Bátkai, et al.
Pageof 18